C17orf78 Inhibitors
C17orf78 kinase inhibitors like staurosporine can alter a wide range of cellular signaling pathways, which might include those associated with C17orf78. Compounds such as LY294002 and rapamycin target specific signaling pathways (PI3K/Akt and mTOR, respectively), which are critical for numerous cellular functions, including protein regulation and synthesis. The function of C17orf78 could be modulated by changes in these pathways.
Similarly, agents that affect cellular stress responses, such as thapsigargin and tunicamycin, may have an impact on C17orf78, as proteins often respond to stress through changes in expression, localization, or degradation. MG132, by inhibiting the proteasome, could potentially increase the half-life of C17orf78 if it is normally degraded through this pathway. Curcumin and sodium butyrate can exert wide-ranging effects on cellular signaling and gene expression, respectively, which may include modulation of proteins like C17orf78. These chemicals represent a broad spectrum of cellular targets and pathways and are not specific to C17orf78.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
A potent kinase inhibitor that can interfere with a broad spectrum of kinases, possibly altering signaling pathways that regulate proteins including C17orf78. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
A PI3K inhibitor that can disrupt the PI3K/Akt pathway, potentially affecting the downstream processes including those associated with C17orf78. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
An mTOR inhibitor that can modulate cell growth and protein synthesis, potentially influencing the expression and function of proteins like C17orf78. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
A MEK inhibitor that can obstruct the MAPK/ERK pathway, potentially altering the regulation of proteins that might interact with or regulate C17orf78. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $40.00 $82.00 $256.00 | 127 | |
Inhibits protein synthesis, possibly leading to decreased expression of proteins, including C17orf78. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $65.00 $210.00 | 26 | |
A glycolysis inhibitor that can lead to energy production impairment, potentially affecting the stability and function of proteins like C17orf78. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $30.00 $52.00 $122.00 $367.00 | 25 | |
Disrupts protein transport by inhibiting the exchange of guanine nucleotide on ARF proteins, potentially impacting the localization and function of C17orf78. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
A SERCA pump inhibitor that can increase cytosolic calcium levels, potentially affecting calcium-dependent signaling pathways and proteins including C17orf78. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $169.00 $299.00 | 66 | |
Inhibits N-linked glycosylation, potentially affecting the stability and localization of glycoproteins, which may include C17orf78 if it is glycosylated. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $56.00 $260.00 $980.00 | 163 | |
A proteasome inhibitor that can increase the levels of proteins by reducing their degradation, possibly affecting the turnover of C17orf78. | ||||||